Landscapes / Targets
CD56
1 drug acts on CD56, in 2 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 14 Feb 2027Phase 1/2 trial completes | |||
| Next date | 14 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC and 2 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026